Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study

J Acquir Immune Defic Syndr. 2006 Jul;42(3):385-7. doi: 10.1097/01.qai.0000221690.54349.83.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • HIV Infections / drug therapy*
  • HIV-1
  • Humans
  • Kidney / drug effects*
  • Middle Aged
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Tenofovir

Substances

  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • Adenine